Mnemosyne Pharmaceuticals Obtains New Financing

  • Feed Type
  • Date
    6/28/2010
  • Company Name
    Mnemosyne Pharmaceuticals
  • Mailing Address
    Undisclosed Providence, RI 02902
  • Company Description
    The company is a Providence-based drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Initial funding will support the founders in recruiting a world-class scientific advisory board, in prosecuting initial patent filings, and in corporate/business development and fund-raising.
  • M&A Terms
  • Venture Investor
    Slater Technology Fund

Trending on Xconomy